Brief: Aurobindo Pharma Says US FDA Classifies Eugia Pharma Unit-II As 'Official Action Indicated'
17/03/2026 12:26
March 17 (Reuters) - Aurobindo Pharma Ltd ARBN.NS: US FDA ISSUES FORM 483 WITH 9 OBSERVATIONS TO EUGIA PHARMA UNIT-II US FDA CLASSIFIES EUGIA PHARMA UNIT-II AS 'OFFICIAL ACTION INDICATED' Source text: ID:nNSE46tRKP Further company coverage: ARBN.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11